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try	 to	 maintain	 cellular	 homeostasis.	 Upon	 hypo‐osmotic	 stress,	 bacteria	 use	
mechanosensitive	 channel	 proteins	 (e.g.	MscL,	MscS)	 to	 release	 large	 amount	 of	
osmolytes	form	the	cell	1,2.	Under	hyper‐osmotic	stress,	bacteria	either	synthesize	
or	 accumulate	 so‐called	 compatible	 solutes	 such	 as	 glycine‐betaine,	 proline	 and	
carnitine	3.	Osmoregulatory	transporters	facilitate	the	uptake	of	compatible	solutes	
across	the	cell	membrane.	Of	these	transporters,	ProP	in	Escherichia	coli	4–8,	BetP	
in	Corynebacterium	glutamicum	 9–13,	 and	OpuA	 in	Lactococcus	 lactis	 14–19	 are	 the	
best	studied.			
OpuA	 (Osmoprotectant	 uptake	 A)	 is	 an	 ATP	 Binding	 Cassette	 (ABC)	 transporter	
that	belongs	to	the	osmoprotectants	taurine	cynate	nitrate	(OTCN)	subfamily.	The	
proteins	of	 this	subfamily	 transport	a	wide	variety	of	substrates	such	as	glycine‐
betaine,	 choline,	 carnitine,	 nitrate,	 cyanate,	 N‐alkylsulfonates	 and	
alkylphosphonates	 20,21.	 Yet,	 OpuA	 from	Lactococcus	 lactis	 is	 rather	 specific	with	
high	 affinity	 for	 glycine	 betaine	 and	 binds	 other	 substrates	 with	 orders	 of	
magnitude	 lower	 affinity	 14,15,22,23.	 Furthermore,	 glycine‐betaine	 is	 a	 compatible	





the	membrane	 surface.	 This	 particular	 helix	 is	 important	 for	maximal	 activity	 of	
OpuA,	but	not	 for	the	 ionic	regulation	of	 transport	19.	Subunit	A	(OpuAA)	has	the	
nucleotide‐binding	 domains	 (NBD)	 fused	 to	 a	 tandem	 cystathionine‐β‐synthase	
(CBSs)	 domain.	 The	 CBS	 module	 controls	 the	 transport	 activity	 through	 an	
electrostatic	 switching	 mechanism	 17,24.	 The	 CBS	 tandem	 is	 approximately	 130	
amino	 acids	 long,	 including	 an	 18	 amino	 acid	 extension	 with	 a	 high	 content	 of	
acidic	 amino	 acids.	 Structural	 analyses	 suggest	 that	 the	 CBS1	 domain	 is	 largely	
unstructured	 and	 the	 ionic	 regulation	 of	OpuA	 is	mediated	 by	 CBS2,	while	 CBS1	
serves	as	a	linker	18.		
OpuA	is	activated	by	an	increase	in	the	internal	ionic	strength,	which	occurs	when	
the	 cells	 are	 exposed	 to	 hyperosmotic	 conditions.	 Mutational	 studies	 of	 OpuA	




interaction	 of	 OpuA	with	 anionic	 lipids	 could	 be	 via	 the	 CBS	module	 or	 another	
protein	domain,	whose	 conformation	 is	 altered	directly	or	 indirectly	by	 the	CBS.	
Deletion	of	the	anionic	tail	of	the	CBS	domain	shifts	the	OpuA	activation	to	higher	
ionic	strength,	while	complete	deletion	of	the	CBS	domain	resulted	in	constitutive	








Even	 though	 OpuA	 has	 been	 studied	 extensively,	 the	 amount	 of	 structural	
information	 is	 still	 limited.	 To	 date,	 only	 the	 structures	 of	 substrate‐binding	
domain	 (OpuAC)	 have	 been	 solved	 in	 open	 (1.9	 Å)	 and	 closed‐liganded	 (2.3	 Å)	
conformations	 23.	 Moreover,	 from	 NMR	 studies	 we	 know	 that	 CBS1	 is	 natively	
unfolded,	 whereas	 CBS2	 has	 a	 structure	 akin	 that	 of	 other	 CBS	 proteins	 18.	
Considering	 the	 complex	 architecture	 and	mechanism	of	 gating	 and	 transport	 of	
OpuA,	 a	 more	 complete	 structural	 analysis	 of	 the	 protein	 is	 required.	 Here,	 we	
focus	on	the	purification	and	stabilization	of	OpuA	with	the	aim	to	crystallize	the	
whole	 protein	 complex.	 We	 used	 an	 OpuA	 mutant	 that	 has	 the	 glutamate‐to‐
glutamine	mutation	(E190Q)	located	in	the	nucleotide‐binding	site.	This	mutation	
is	expected	to	 trap	the	ABC	protein	 in	an	 intermediate	state	as	was	observed	 for	
the	maltose	 transporter	 25	 and	 the	multidrug	 transporter	BmrA	 26.	The	mutation	
abolishes	the	ability	of	protein	to	hydrolyze	ATP,	and	therefore	traps	the	protein	in	
the	ATP‐bound	state.	OpuA	(E190Q)	stability	was	tested	in	different	detergents,	pH	






The	 choice	 of	 detergent	 is	 an	 important	 factor	 in	 membrane	 protein	 studies,	
including	 stability	 studies,	 functional	 assays	 and	 crystallization.	 Detergents	 are	
required	for	extraction	of	proteins	from	membranes	and	to	keep	them	in	solution.	




amphipathic	 molecules,	 consisting	 of	 a	 polar	 head	 group	 and	 a	 hydrophobic	
moiety,	 often	 an	 alkyl	 chain.	 The	 head	 groups	 are	 typically	 uncharged	 or	
zwitterionic,	 but	 charged	 detergents	 are	 also	 available.	 With	 respect	 to	 their	
hydrophilic	portions	(head	group),	detergents	fall	into	four	major	categories:	ionic,	
nonionic,	 bile	 acid	 salts,	 and	 zwitterionic	 28.	 Nonionic	 detergents	 include	








purification	 30.	 The	 stability	 and	 monodispersity	 of	 the	 membrane	 protein	 in	
detergents	 was	 assayed	 by	 size‐exclusion	 chromatography	 (SEC)	 29.	 Thus,	 the	








types	that	differ	 in	the	hydrophobic	chain	 length	or	structure	of	 the	hydrophobic	
moiety,	 such	 as	 octyl‐maltoside	 (OM),	 nonyl‐maltoside	 (NM),	 decyl‐maltoside	




glucoside	 (OG),	 Anapoe	 C12E8	 and	 zwitterionic	 detergents	 such	 as	 dodecyl	
dimethylamine	oxide	(LDAO),	Foscholine‐10,	and	Foscholine‐12	were	also	tested.	
The	properties	of	detergents	used	in	this	study	are	shown	in	Table	1.	
The	 SEC	 eluent	 profile	 of	 OpuA(E190Q)	 was	 used	 to	 judge	 the	 quality	 of	 the	
purified	protein	by	monitoring	the	occurrence	of	aggregates,	the	monodispersity	of	
the	 peak,	 and	 the	 integrity	 of	 the	 protein	 complex.	 From	 the	 eleven	 detergents	
tested,	DDM	was	the	best	candidate	that	preserved	the	integrity	and	stability	of	the	
OpuA(E190Q)	 complex	 (Figure	 2).	 OpuA(E190Q)	 was	 eluted	 as	 a	 single	 eluent	
peak,	 in	 which	 the	 OpuAA	 to	 OpuABC	 ratio	 was	 close	 to	 1.	 Protein	 complex	
dissociation	was	observed	with	shorter	alkyl	chain	of	the	maltoside	detergent	(e.g.	
UDM,	 DM,	 or	 NM).	 This	 complex	 dissociation	 was	 inferred	 from	 SDS‐PAA	 gel	
electrophoresis	of	the	peak	fractions,	typically	resulting	in	OpuAA/OpuABC	ratios	
<	1.	In	the	case	of	NM,	only	OpuAA	remained	in	the	SEC‐eluent	profile	(data	is	not	
shown).	 Protein	 complex	 dissociation	 also	 occurred	 in	 the	 maltoside	 detergent	
with	 cyclohexyl‐alkyl	 chain	 (Cymal5	 and	 Cymal6),	 OG,	 Foscholine‐10,	 and	
Foscholine‐12.	 Three	 of	 these	 detergents	 (OG,	 Foscholine‐10	 and	 Foscholine‐12)	
induced	 a	 complete	 dissociation	 of	 OpuAA	 and	 OpuABC.	 Three	 detergents	 (OM,	
C12E8,	and	LDAO)	induced	protein	aggregation,	which	appeared	in	the	void	volume	





the	 length	 of	 the	 hydrophobic	 alkyl	 chain,	 DDM	 creates	 a	 large	 detergent	 belt	
around	the	membrane	protein	that	may	prohibit	the	formation	of	crystal	contacts.	
Since	the	detergent	exchange	of	OpuA(E190Q)	in	the	IMAC	step	was	not	successful,	




3).	The	 ratio	of	OpuAA/OpuABC	was	 close	 to	1	and	 the	peak	was	monodisperse.	




































































































































































































































































































































































































































































‐lipid	 +		lipid	 ‐lipid	 +		lipid	 ‐lipid	 +		lipid	
DDM	 11	 10.59	 10.33	 1.86	 1.59	 ~1	 ~1	
UDM	 42	 11.05	 10.49	 1.57	 1.51	 ~1	 ~1	
DM	 116	 10.99	 11.23	 1.75	 1.74	 ~1	 ~1	










OM	 1	 9.1	 Aggregation	
NM	 0.6	 nd	 Partial	complex	dissociation	
DM	 0.2	 12.8	 Partial	complex	dissociation	
UDM	 0.06	 11.2	 Partial	complex	dissociation	
DDM	 0.02	 10.6	 Stable	complex	
Cymal	5	 0.3	 12.8	 Partial	complex	dissociation	
Cymal	6	 0.06	 11.8	 Partial	complex	dissociation	
Octylglucoside	 1	 12.9	 Complex	dissociation	
C12E8	 0.01	 8.0	 Aggregation	
Foscholine‐10	 0.6	 13.1	 Complex	dissociation	
Foscholine‐12	 0.1	 12.9	 Complex	dissociation	







6.4,	pH	7.5	or	pH	8.5.	The	protein	was	eluted	 in	buffer	 at	 the	 corresponding	pH.	
The	eluent	fractions	of	OpuA(E190Q)	from	the	first	SEC	run	were	kept	at	8	°C	and	
after	 one	 week	 this	 OpuA(E190Q)	 fraction	 was	 rerun	 on	 the	 SEC	 column.	 The	
eluent	profiles	of	OpuA(E190Q)	of	 the	 first	and	the	second	SEC	run	are	shown	in	
Figure	4.	At	pH	5.5,	and	pH	6.4	the	eluent	peak	of	OpuA(E190Q)	displayed	tailing	














The	 oligomeric	 state	 of	 OpuA(E190Q)	 was	 determined	 by	 SEC	 coupled	 to	 light	
scattering	 experiments	 (SEC‐MALLS)	 35.	 OpuA(E190Q)	 is	 present	 as	 a	 dimer	 in	
detergent	solutions	with	molecular	mass	of	214	kDa	(Figure	5).		
	
Figure	 5.	 SEC‐MALLS	 analysis	 of	 OpuA	 (E190Q).	 The	 chromatogram	 from	 SEC	 is	 shown.	 Key:	 dotted	
lines,	 signal	 from	 the	 refractive	 index	 detector;	 dashed	 line,	 signal	 from	 the	 static	 light	 scattering	
detector	at	90;	 solid	black	 line,	 signal	 from	absorption	at	280	nm;	solid	grey	 line,	 calculated	protein	
molecular	 weight	 (scale	 on	 right–hand	 y	 axis).	 OpuA	 has	 an	 observed	 mass	 of	 214	 kDa,	 which	
corresponds	to	a	dimer	of	two	AA	and	two	ABC	subunits	(the	calculated	mass	is	217	kDa).	
1.2.3 Crystallization	
Crystallizations	 of	 OpuA(E190Q)	 were	 set	 up	 based	 on	 the	 vapor	 diffusion	
technique,	in	which	a	drop	containing	a	mixture	of	protein	[purified	OpuA(E190Q)]	
and	precipitant	is	sealed	in	a	chamber	where	there	is	also	a	separate	reservoir	of	
pure	 precipitant	 solution.	 The	 drop	 contains	 lower	 concentration	 of	 precipitant	
than	 the	 reservoir,	 thus	 water	 vapor	 leaves	 the	 drop	 until	 the	 equilibrium	 is	
achieved,	 ideally	 in	 the	 crystal	 nucleation	 zone	of	 the	phase	diagram	 36.	We	 also	
tried	 crystallization	 using	 the	 lipidic	 sponge	 phase	 (LSP)	 27,	 which	 has	 been	
developed	 based	 on	 lipidic	 cubic	 phase	 (LCP)	 technique	 37.	 Lipidic‐cubic	 phase	




27.	 Moreover,	 LSP	 is	 liquid	 at	 room	 temperature,	 making	 it	 compatible	 with	 the	
vapor	 diffusion	 crystallization	 technique.	 In	 LSP	 crystallization,	 a	 droplet	
		 131	
Crystallization	of	OpuA
containing	 purified	 membrane	 protein	 is	 mixed	 with	 LSP	 solutions	 and	
equilibrated	 against	 reservoir	 solution	 containing	 LSP	 solution	 in	 the	 sealed	
chamber,	similar	to	the	conventional	vapor	diffusion	technique.	
Crystallization	 of	 OpuA(E190Q)	 was	 carried	 out	 in	 buffer	 C	 containing	 20	 mM	
Hepes	pH	7.5,	20%	glycerol,	and	150	mM	NaCl.	We	used	DDM,	UDM,	DM,	OM,	or	
Cymal6	 as	 the	 detergent,	 and	 added	 lipids	 as	 specified	 in	 Appendix	 I.	
Crystallization	 using	 conventional	 sparse‐matrix	 screenings	 (JCSG,	 Structure	
Screen,	 PACT	 premier	 etc)	 did	 not	 result	 in	 crystal	 hits.	 However,	 crystals	
appeared	 from	Lipidic	 Sponge	 Phase	 (LSP)	 conditions	 #8	 (Monoolein,	Mes	 pH	 6	







lipid‐structure	was	 formed	 in	 the	middle	 of	 the	 crystallization	 drop	 and	 protein	
crystals	grew	around	this	lipid	structure	(Figure	6;	panel	A,	B,	C).	Even	though	the	
crystals	from	LSP	were	reproducible,	the	sizes	of	the	crystals	were	often	too	small	
for	X‐ray	diffractions.	Furthermore,	 the	crystals	often	stick	 to	 the	 lipid	 structure,	
therefore	are	difficult	to	fish.	Despite	these	limitations,	we	managed	to	fish	several	
crystals	 and	 had	 them	 tested	 for	 diffraction,	 however,	 none	 of	 them	 diffracted.	
Efforts	were	made	 to	 optimize	 crystals	 from	 LSP	 by	 varying	 the	monoolein	 and	
Chapter	6	
132	















was	 expressed	 in	 the	 Opu401,	 a	 L.	 lactis	 NZ9000	 opuA	 null	 strain.	 L.	 lactis	 cells	
were	grown	semi‐anaerobically	at	30	°C	in	a	10	liter	pH‐regulated	fermentor.	The	
medium	contained	of	2%	(w/v)	Gistex,	65	mM	sodium	phosphate	 (NaPi)	pH	6.5,	
1%	 (w/v)	D‐glucose)	and	5	μg/ml	 chloramphenicol.	The	 culture	was	 induced	by	
the	 addition	of	0.05%	 	 (v/v)	 culture	 supernatant	of	 the	nisin	A‐producing	 strain	
NZ9700	41,	 followed	by	an	extra	addition	of	1%	(w/v)	D‐glucose	at	30C.	After	2	
hours	of	induction,	cells	were	harvested	by	centrifugation	(8000	rpm,	JLA	8.1000	







EDTA	pH	7.5	was	added	to	 the	cell	 lysate.	The	cell	debris	was	removed	 from	the	




90	 minutes	 at	 4	 °C).	 The	 pellet	 fraction	 (containing	 membrane	 vesicles)	 was	
resuspended	in	50	mM	KPi	pH	7.0,	plus	20%	(v/v)	glycerol	to	a	concentration	of	~	
20	mg/ml	of	total	protein.	
Membrane	 vesicles	 containing	 OpuA(E190Q)	 were	 diluted	 to	 a	 final	 protein	
concentration	of	5	mg/ml	 in	buffer	A	(50	mM	KPi	pH	7.5,	20	%	glycerol	and	200	
mM	NaCl).	The	protein	was	solubilized	with	0.5	%	(w/v)	n‐dodecyl‐‐D‐maltoside	
(DDM)	 for	 30	 minutes	 on	 ice	 with	 gentle	 mixing	 every	 10	 min.	 The	 insoluble	
fraction	 was	 removed	 by	 ultracentrifugation	 (80.000	 rpm,	 TLA	 100.4,	 for	 15	
minutes	at	4	°C).	The	solubilized	fraction	was	diluted	5x	and	was	 incubated	with	
0.5	ml	 (bed	 volume)	 pre‐equilibrated	 nickel‐Sepharose	 for	 1	 hour	 at	 4	 °C	 in	 the	
presence	 of	 15	mM	 Imidazole.	 Subsequently,	 the	 resin	was	 poured	 into	 a	 10	ml	
disposable	column	(BioRad),	and	washed	with	20‐column	volumes	(CV)	of	buffer	B	
(20	mM	Hepes	pH	7.5,	20	%	glycerol,	200mM	NaCl)	containing	0.02	%	DDM	plus	
50	 mM	 Imidazole.	 The	 protein	 was	 eluted	 in	 3	 eluent	 fractions,	 using	 buffer	 B	
containing	 0.02	 %	 DDM	 plus	 200	 mM	 Imidazole.	 The	 second	 eluent	 fraction	




To	 determine	 the	 OpuA(E190Q)	 stability	 in	 different	 detergents,	 membrane	
vesicles	 and	 solubilized	 protein	 were	 prepared	 as	 described	 in	 the	 previous	
sections.	 Following	 ultracentrifugation	 (45.000	 rpm,	 Ti	 50.2,	 for	 90	 minutes	 at	
4	 °C)	 to	 remove	membrane	 and	 insoluble	 components,	 the	 soluble	 fraction	was	
incubated	with	nickel‐Sepharose	resin	for	1h	at	4°C.	The	resin	was	washed	with	20	
column‐volumes	(CV)	of	buffer	B	containing	50	mM	imidazole	and	detergent	X	(X	=	
LDAO,	 OG,	 UDM,	 NM,	 DM,	 OM,	 Cymal5,	 Cymal6,	 Anapoe	 C12E8,	 Foscholine‐10,	 or	
Foscholine‐12).	 Detergents	 were	 used	 at	 2‐3	 times	 their	 critical	 micelle	
concentration	(CMC)	unless	stated	otherwise.	The	protein	was	eluted	with	buffer	B	
containing	200	mM	Imidazole	and	detergent.	The	subsequent	eluent	fraction	was	
loaded	onto	a	Superdex	200	10/300	GL	 size‐exclusion	 column	and	 run	at	 a	 flow	
rate	 of	 0.2	 ml/min	 at	 4	 °C	 in	 buffer	 containing	 20	 mM	 K‐Hepes	 pH	 7.5,	 20	 %	

















doubled.	 The	 OpuA(E190Q)	 containing	 eluent	 fractions	 were	 pooled	 and	
concentrated	 to	 10‐20	 mg/ml.	 Prior	 to	 setting	 up	 the	 crystallization	 trials,	 the	
protein	was	centrifuged	at	full	speed	in	an	Eppendorf	table‐top	centrifuge	(14000	
rpm	for	20	min	at	4	°C).		
The	 crystallization	 trials	 were	 performed	 using	 the	 commercial	 sparse‐matrix	
screens	 available:	 JCSG	 (Qiagen),	 MemGold	 (Molecular	 dimension),	 MemStart‐
MemSys	 (Molecular	 dimension),	 Structure	 Screen	 (Molecular	 dimension),	 PACT	
premier	 (Molecular	dimension),	 Cryo	 I	&	 II	 (Emerald	Biosystem),	Lipidic	Sponge	
Phase	 (Molecular	 dimension),	 Additive	 screen	 (Hampton).	 	 A	 200	 nl	 drop	
containing	protein	 and	 screening	 solution	 (ratio	1:1)	was	made	by	 the	Mosquito	
automatic	 pipetting	 robot	 (TTP	 labtech).	 	 The	 crystallizations	 were	 set	 up	 as	 a	
sitting	drops	in	a	96	well	plate	(MRC2)	by	vapor	diffusion	method.		The	plates	were	
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DDM	 14		 buffer	C	 JCSG,	Structure	Screen	
1&2	
none	
	 	 0.02%	DDM	 MemGold,	MemStart‐
MemSys	
none	
	 	 	 Cryo	1&2,Pact	premier	 none	
	 	 	 	 	
	 12.31	 buffer	C	 JCSG,	Structure	Screen	
1&2	
none	
	 	 0.02%DDM	 MemGold,	MemStart‐
MemSys	
none	
	 	 5mM	Mg‐ATP	 Cryo	1&2,Pact	premier	 none	
	 	 	 	 	
	 12.31		 buffer	C	 JCSG,	Structure	Screen	
1&2	
none	
	 	 0.02%DDM	 MemGold,	MemStart‐
MemSys	
none	
	 	 1	mM	GB	 Cryo	1&2,Pact	premier	 none	
	 	 	 	 	
	 13.45		 buffer	C	 JCSG,	Structure	Screen	
1&2	
none	
	 	 0.04%	DDM	 MemGold,	MemStart‐
MemSys	
none	
	 	 0.005%	lipid	 Cryo	1&2,Pact	premier	 none	
	 	 	 	 	
	 15.22		 buffer	C	 JCSG,	Structure	Screen	
1&2	
none	
	 	 0.04%	DDM	 MemGold,	MemStart‐	 none	
	 	 0.005%	lipid	 MemSys,	Cryo1&2,	PACT	 none	
	 	 2	mM	Mg‐ATP		 	
	 	 4oC	and	18oC	 	 	
	 	 	 	 	
	 15.22		 buffer	C	 JCSG,	Structure	Screen	
1&2	
none	
	 	 0.04%	DDM	 MemGold,	MemStart‐	 none	
	 	 0.005%	lipid	 MemSys	 none	
	 	 2	mM	GB	 Cryo	1&2,Pact	premier	 	
	 	 4oC	and	18oC	 	 	




DDM	 15.65		 buffer	C	 JCSG,	Pact	premier	 none	
	 	 0.02%	DDM	 MenGold,	Cryo1&2	 none	
	 	 single	 	
	 	 step	purification	 	
	 	 	 	 	
	 6.4		 buffer	C	 Lipicic	Sponge	Phase		 crystal,		
	 	 0.02%	DDM	 (LSP)	 Not	
diffract	
	 	 	 	 	
	 6.4	‐	8.67		 buffer	C	 Lipicic	Sponge	Phase	 crystal,		
	 	 0.02%DDM	 	 unfishable	
	 	 1	mM	GB	 	 	
	 	 	 	 	
	 6.5		 buffer	C	 Lipicic	Sponge	Phase	 crystals	
	 	 0.02%	DDM	 	 not	
diffract	
	 	 3	mm	Mg‐ATP	 	
	 	 	 	 	
DDM	 6.4	‐	8.67		 buffer	C	 Lipicic	Sponge	Phase	
(LSP)	
crystal	
	 	 0.02%DDM	 	
	 	 2	mM	Mg‐ATP	 	
	 	 	 	 	
	 6.3		 buffer	C	 LSP	with	additive	screen	 none	
	 	 0.02%	DDM	 	
	 	 	 	 	
	 6.5		 buffer	C	 Lipicic	Sponge	Phase	 none	
	 	 0.09%	DDM	 	
	 	 0.005%	lipid	 	
	 	 	 	 	
	 6.5		 buffer	C	 Lipicic	Sponge	Phase	 none	
	 	 0.09%	DDM	 	
	 	 0.005%	lipid	 	
	 	 2	mM	Mg‐ATP	 	
	 	 	 	 	
	 37.5		 buffer	C	 LSP	optimization	 none	
	 	 0.02%	DDM	 	
	 	 	 	 	
	 18.75		 buffer	C	 LSP	optimization	 none	
	 	 0.02%	DDM	 	
	 	 	 	 	
	 6.5		 buffer	C	 LSP	optimization	 none	
	 	 0.02%	DDM	 	





UDM	 11.93		 buffer	C	 JCSG,	Structure	Screen	
1&2	
none	
	 	 0.06%	UDM	 MemGold,	MemStart‐
MemSys	
none	
	 	 	 Cryo	1&2,Pact	premier	 none	
	 	 	 	 	
	 11.93		 buffer	C	 JCSG,	Structure	Screen	
1&2	
none	
	 	 0.06%	UDM	 MemGold,	MemStart‐
MemSys	
none	
	 	 2mM	Mg‐ATP	 Cryo	1&2,Pact	premier	 none	
	 	 	 	 	
	 19.68		 buffer	C	 JCSG,	Structure	Screen	
1&2	
none	
	 	 0.15%	UDM	 MemGold,	MemStart‐
MemSys	
none	
	 	 0.005%	lipid	 Cryo	1&2,Pact	
premier,wizard	
none	
	 	 2	mM	Mg‐ATP	 	
	 	 2mM	GB	 	
	 	 18oC	 	 	
	 	 	 	 	
DM	 14		 buffer	C	 JCSG,	Structure	Screen	
1&2	
none	
	 	 0.2%	DM	 MemGold,	MemStart‐
MemSys	
none	
	 	 2	mM	Mg‐ATP	 Cryo	1&2,Pact	premier	 none	
	 	 	 	 	
	 6.5		 buffer	C	 Lipidic	Sponge	Phase	 crystal	
	 	 0.2%	DM	 	
	 	 2	mM	Mg‐ATP	 	
	 	 	 	 	
	 6.5		 buffer	C	 Lipidic	Sponge	Phase	 none	
	 	 0.2%	DM	 	
	 	 	 	 	
	 6.5		 buffer	C	 Lipidic	Sponge	Phase	 none	
	 	 0.2%	DM	 	
	 	 2	mM	Mg‐ATP	 	
OM	 6.5		 buffer	C	 Lipidic	Sponge	Phase	 none	
	 	 1	%	OM	 	 	
	 	 2mM	Mg‐ATP	 	 	







Cymal	6	 6.5‐14		 buffer	C	 Lipicic	Sponge	Phase	 crystal		
	 	 0.06%	Cymal6	 	
	 	 	 	 	
	 13.77		 buffer	C	 JCSG,	Structure	Screen	
1&2	
none	
	 	 0.06%	Cymal6	 MemGold,	MemStart‐
MemSys	
none	
	 	 2	mM	Mg‐ATP	 Cryo	1&2,Pact	premier	 none	
	 	 	 	 	
	 20.82		 buffer	C	 JCSG,	Structure	Screen	
1&2	
none	
	 	 0.15%	Cymal6	 MemGold,	MemStart‐
MemSys	
none	
	 	 0.005%	lipid	 Cryo	1&2,Pact	premier	 none	
	 	 2	mM	Mg‐ATP	 	
	 	 2mM	GB	 	
	 	 18oC	 	 	
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